Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Isabelle Rooney
Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-Treated Patients With BRAFV600-mutated Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Thrombophilic Status May Predict Prognosis in Patients With Metastatic BRAFV600-mutated Melanoma Who Are Receiving BRAF Inhibitors
Journal of the American Academy of Dermatology
Dermatology
Vemurafenib Has Activity in Patients With BRAFV600-Mutant Glioma
Cancer Discovery
Oncology
Targeting Epigenetics for Treatment of BRAF Mutated Metastatic Melanoma With Decitabine in Combination With Vemurafenib: A Phase Lb Study
Oncotarget
Oncology
Metastatic Melanoma and Vemurafenib: Novel Approaches
Rare Tumors
Oncology
Histology
Biomarker Analysis of On-Treatment and at Progression Biopsies From BRIM7 - A Phase 1B Trial of Combined Vemurafenib and Cobimetinib Treatment in BRAF V600 Mutated Melanoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Simultaneous Treatment of Severe Vemurafenib-Induced Uveitis and Metastatic Melanoma
Journal of Clinical & Experimental Ophthalmology
Prognostic Factors Related to Clinical Response in Patients With Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade
Clinical Cancer Research
Cancer Research
Oncology
Successful Dabrafenib Transition After Vemurafenib-Induced Toxic Epidermal Necrolysis in a Patient With Metastatic Melanoma
JAAD Case Reports
Dermatology
Risk Factors for Severe Rash With Use of Vemurafenib Alone or in Combination With Cobimetinib for Advanced Melanoma: Pooled Analysis of Clinical Trials
BMC Cancer
Cancer Research
Oncology
Genetics
